Literature DB >> 25914468

Individual having a parent with early-onset gastric cancer may need screening at younger age.

Hee-Won Kwak1, Il Ju Choi1, Chan Gyoo Kim1, Jong Yeul Lee1, Soo-Jeong Cho1, Bang Wool Eom1, Hong Man Yoon1, Jungnam Joo1, Keun Won Ryu1, Young-Woo Kim1.   

Abstract

AIM: To evaluate whether individuals with gastric cancer (GC) are diagnosed earlier if they have first-degree relatives with GC.
METHODS: A total of 4282 patients diagnosed with GC at National Cancer Center Hospital from 2002 to 2012 were enrolled in this retrospective study. We classified the patients according to presence or absence of first-degree family history of GC and compared age at diagnosis and clinicopathologic characteristics. In addition, we further classified patients according to specific family member with GC (father, mother, sibling, or offspring) and compared age at GC diagnosis among these patient groups. Baseline characteristics were obtained from a prospectively collected database. Information about the family member's age at GC diagnosis was obtained by questionnaire.
RESULTS: A total of 924 patients (21.6%) had a first-degree family history of GC. The mean age at GC diagnosis in patients having paternal history of GC was 54.4 ± 10.4 years and was significantly younger than in those without a first-degree family history (58.1 ± 12.0 years, P < 0.001). However, this finding was not observed in patients who had an affected mother (57.2 ± 10.0 years) or sibling (62.2 ± 9.8 years). Among patients with family member having early-onset GC (< 50 years old), mean age at diagnosis was 47.7 ± 10.3 years for those with an affected father, 48.6 ± 10.4 years for those with an affected mother, and 57.4 ± 11.5 years for those with an affected sibling. Thus, patients with a parent diagnosed before 50 years of age developed GC 10.4 or 9.5 years earlier than individuals without a family history of GC (both P < 0.001).
CONCLUSION: Early-onset GC before age of 50 was associated with parental history of early-onset of GC. Individual having such family history need to start screening earlier.

Entities:  

Keywords:  Age at diagnosis; Family history; Family member; Gastric cancer; Screening

Mesh:

Year:  2015        PMID: 25914468      PMCID: PMC4402306          DOI: 10.3748/wjg.v21.i15.4592

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  Guidance on large bowel surveillance for people with two first degree relatives with colorectal cancer or one first degree relative diagnosed with colorectal cancer under 45 years.

Authors:  M G Dunlop
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

2.  Association of family history with cancer recurrence and survival in patients with gastric cancer.

Authors:  Mi Ah Han; Myueng Guen Oh; Il Ju Choi; Sook Ryun Park; Keun Won Ryu; Byung-Ho Nam; Soo-Jeong Cho; Chan Gyoo Kim; Jun Ho Lee; Young-Woo Kim
Journal:  J Clin Oncol       Date:  2012-01-23       Impact factor: 44.544

3.  Family history and the risk of stomach cancer death in Japan: differences by age and gender.

Authors:  Hiroshi Yatsuya; Hideaki Toyoshima; Tetsuya Mizoue; Takaaki Kondo; Koji Tamakoshi; Yoko Hori; Noritaka Tokui; Yoshiharu Hoshiyama; Shogo Kikuchi; Kiyomi Sakata; Norihiko Hayakawa; Akiko Tamakoshi; Yoshiyuki Ohno; Takesumi Yoshimura
Journal:  Int J Cancer       Date:  2002-02-10       Impact factor: 7.396

4.  Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.

Authors:  D G Huntsman; F Carneiro; F R Lewis; P M MacLeod; A Hayashi; K G Monaghan; R Maung; R Seruca; C E Jackson; C Caldas
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

Review 5.  Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.

Authors:  Parry Guilford; Bostjan Humar; Vanessa Blair
Journal:  Gastric Cancer       Date:  2010-04-07       Impact factor: 7.370

6.  E-cadherin germline mutations in familial gastric cancer.

Authors:  P Guilford; J Hopkins; J Harraway; M McLeod; N McLeod; P Harawira; H Taite; R Scoular; A Miller; A E Reeve
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

7.  Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.

Authors:  Svein Hansen; Stein Emil Vollset; Mohammad H Derakhshan; Valerie Fyfe; Kjetil K Melby; Steinar Aase; Egil Jellum; Kenneth E L McColl
Journal:  Gut       Date:  2007-02-22       Impact factor: 23.059

8.  Family history and the risk of stomach and colorectal cancer.

Authors:  C La Vecchia; E Negri; S Franceschi; A Gentile
Journal:  Cancer       Date:  1992-07-01       Impact factor: 6.860

Review 9.  Helicobacter pylori and gastric carcinogenesis.

Authors:  P Correa
Journal:  Am J Surg Pathol       Date:  1995       Impact factor: 6.394

10.  Family history and the risk of gastric cancer.

Authors:  M Yaghoobi; R Bijarchi; S A Narod
Journal:  Br J Cancer       Date:  2009-11-03       Impact factor: 7.640

View more
  9 in total

1.  British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.

Authors:  Matthew Banks; David Graham; Marnix Jansen; Takuji Gotoda; Sergio Coda; Massimiliano di Pietro; Noriya Uedo; Pradeep Bhandari; D Mark Pritchard; Ernst J Kuipers; Manuel Rodriguez-Justo; Marco R Novelli; Krish Ragunath; Neil Shepherd; Mario Dinis-Ribeiro
Journal:  Gut       Date:  2019-07-05       Impact factor: 23.059

Review 2.  Is early-onset cancer an emerging global epidemic? Current evidence and future implications.

Authors:  Tomotaka Ugai; Naoko Sasamoto; Hwa-Young Lee; Mariko Ando; Mingyang Song; Rulla M Tamimi; Ichiro Kawachi; Peter T Campbell; Edward L Giovannucci; Elisabete Weiderpass; Timothy R Rebbeck; Shuji Ogino
Journal:  Nat Rev Clin Oncol       Date:  2022-09-06       Impact factor: 65.011

Review 3.  Molecular alterations in gastric cancer with special reference to the early-onset subtype.

Authors:  Małgorzata Skierucha; Anya Na Milne; G Johan A Offerhaus; Wojciech P Polkowski; Ryszard Maciejewski; Robert Sitarz
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

Review 4.  Gastric cancer and family history.

Authors:  Yoon Jin Choi; Nayoung Kim
Journal:  Korean J Intern Med       Date:  2016-11-01       Impact factor: 2.884

5.  NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population.

Authors:  Xiaoying Chen; Yong Yang; Jing Liu; Bin Li; Yan Xu; Cong Li; Qi Xu; Guili Liu; Yingmin Chen; Jieer Ying; Shiwei Duan
Journal:  Oncotarget       Date:  2017-01-31

6.  The prognostic value of age in non-metastatic gastric cancer after gastrectomy: a retrospective study in the U.S. and China.

Authors:  Jieyun Zhang; Lu Gan; Mi-Die Xu; Mingzhu Huang; Xiaowei Zhang; Yiwei Gong; Xi Wang; Guanzhen Yu; Weijian Guo
Journal:  J Cancer       Date:  2018-03-08       Impact factor: 4.207

7.  Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer.

Authors:  Valli De Re; Enrico Orzes; Vincenzo Canzonieri; Stefania Maiero; Mara Fornasarig; Lara Alessandrini; Silvia Cervo; Agostino Steffan; Giorgio Zanette; Cinzia Mazzon; Paolo De Paoli; Renato Cannizzaro
Journal:  Clin Transl Gastroenterol       Date:  2016-07-21       Impact factor: 4.488

8.  Prevalence of gastric cancer precursors in gastroscopy-screened adults by family history of gastric cancer and of cancers other than gastric.

Authors:  Rui Wu; Cheng Yang; Lin Ji; Zhi-Ning Fan; Yu-Wen Tao; Qiang Zhan
Journal:  BMC Cancer       Date:  2020-11-16       Impact factor: 4.430

9.  Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP).

Authors:  Jonathan W J Lee; Feng Zhu; Supriya Srivastava; Stephen Kk Tsao; Christopher Khor; Khek Yu Ho; Kwong Ming Fock; Wee Chian Lim; Tiing Leong Ang; Wan Cheng Chow; Jimmy Bok Yan So; Calvin J Koh; Shijia Joy Chua; Andrew S Y Wong; Jaideepraj Rao; Lee Guan Lim; Khoon Lin Ling; Chung-King Chia; Choon Jin Ooi; Andrea Rajnakova; Wai Ming Yap; Manuel Salto-Tellez; Bow Ho; Richie Soong; Kee Seng Chia; Yik Ying Teo; Ming Teh; Khay-Guan Yeoh
Journal:  Gut       Date:  2021-05-11       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.